NCT03735810View on ClinicalTrials.gov

Safety and Tolerability Study of LBS-008 in Healthy Adult Subjects After Single and Multiple Doses

PHASE1CompletedINTERVENTIONAL

Enrollment

71

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

September 16, 2019

Study Completion Date

September 16, 2019

Conditions

Healthy Volunteer

Interventions

DRUG

LBS-008

LBS-008 oral capsules

DRUG

Placebos

Oral capsules

Trial Locations (1)

6009

Linear Clinical Research, Perth

Sponsors

Collaborators (1)

Belite Bio, Inc

All Listed Sponsors

collaborator

Belite Bio, Inc

INDUSTRY

lead

RBP4 Pty Ltd

INDUSTRY

NCT03735810 - Safety and Tolerability Study of LBS-008 in Healthy Adult Subjects After Single and Multiple Doses | Biotech Hunter | Biotech Hunter